Suppression of toxic transgene expression by optimized artificial miRNAs increases AAV vector yields in HEK-293 cells
Open Access
- 10 June 2024
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 32 (3) , 101280
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
This publication has 41 references indexed in Scilit:
- Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into ratsGenetic Vaccines and Therapy, 2008
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Argonaute2 Is the Catalytic Engine of Mammalian RNAiScience, 2004
- Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control unitsVirology, 2003
- Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 VectorsHuman Gene Therapy, 2002
- A microRNA in a Multiple-Turnover RNAi Enzyme ComplexScience, 2002
- In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1).2002
- Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectorJournal of Virology, 1996
- The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell, 1993
- Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegansCell, 1993